Howard Safir's most recent trade in Citius Pharmaceuticals Inc was a trade of 75,000 Options to Purchase Common Stock done . Disclosure was reported to the exchange on Oct. 4, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Oct 2022 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Oct 2021 | 75,000 | 75,000 | - | - | Options to Purchase Common Stock | |
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jul 2021 | 15,000 | 15,000 | - | - | Options to Purchase Common Stock | |
| Verint Systems, Inc. | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Apr 2021 | 4,178 | 30,838 (0%) | 0% | 0 | Common Stock | |
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 25,000 | 25,000 | - | - | Options to Purchase Common Stock | |
| Verint Systems, Inc. | Howard Safir | Director | Sale of securities on an exchange or to another person at price $ 60.21 per share. | 14 Dec 2020 | 8,333 | 24,693 (0%) | 0% | 60.2 | 501,730 | Common Stock |
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Oct 2020 | 35,000 | 35,000 | - | - | Options to Purchase Common Stock | |
| Verint Systems, Inc. | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2020 | 4,326 | 33,026 (0%) | 0% | 0 | Common Stock | |
| Citius Pharmaceuticals Inc | Howard Safir | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2020 | 25,000 | 25,000 | - | - | Options to Purchase Common Stock |